Clinical Trials Directory

Trials / Completed

CompletedNCT00261209

Collagenase in the Treatment of Zone II Flexor Tendon Adhesions in the Hand

Study of Collagenase Injection Therapy for Treatment of Zone II Flexor Tendon Adhesions in the Hand

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
3 (actual)
Sponsor
Stony Brook University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to dissolve flexor tendon adhesions associated with failed tendon repair surgery.

Detailed description

In an open label study, collagenase injection therapy was investigated in 3 subjects for it's ability to lyse flexor tendon adhesions in zone II of the hand. Results indicate that two of three subjects had improved range of finger motion at the PIP and DIP joints. This may obviate the need for patients to have tenolysis hand surgery to correct the finger flexion contracture of the PIP and DIP joints. Detailed controlled studies remain to be done.

Conditions

Interventions

TypeNameDescription
DRUGCollagenaseCollagenase injection into adhesion restricting tendon gliding
DRUGCollagenase injectioninjection of collagenase into adhesion restricting tendon gliding

Timeline

Start date
2005-01-01
Primary completion
2008-01-01
Completion
2008-01-01
First posted
2005-12-02
Last updated
2016-04-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00261209. Inclusion in this directory is not an endorsement.